Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why did the reporting for this quarter end on 1/31/2008?

In the past, the company has been pretty good at reporting all the licenses reported through the end of the quarter and other licenses signed for about a month after the end. This time, they only report financial results through the end of January 2008, when our quarter ends 2/29/2008. What exactly happened in February that the company and/or TPL does not was to make public knowledge at this time? We all know of the 5 licenses signed in February, but is there anything else? Any thoughts?

The 10Q fully reported the financial results for the period ending 2/29/2008. What can not be reported is income pending receipt by PDS.

Goerner's letter merely pointed out that fees from 2/1/2008 onwards had not yet been received/distibuted from the licensees. The material event is the additional licensee, not the terms of the payment.

Aren't 90-day and 120-day settlement periods standard business practice?

Be well

Share
New Message
Please login to post a reply